What this means
A trial plans to compare silkworm pupa powder with a look-alike placebo in Alzheimer's patients for 3 months. No results have been posted, so we do not know if it works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 50–90
- Where
- 1 site
The science
- Registered title
- A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients with Alzheimer's Disease.
- Trial ID
- NCT06770309 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Alzheimer Disease (AD), Sarcopenia, Asthenia
- What is tested
- Silkworm pupa powder, Placebo
- Sponsor
- Yanbu Ke
- Ages
- 50 Years to 90 Years
- Dates
- First posted Jan 13, 2025 · updated Jan 13, 2025
Registry summary
The goal of this clinical trial is to learn if silkworm pupa powder works to improve the nutritional status of Alzheimer's disease patients. The main questions it aims to answer are:
- Does silkworm pupa powder evaluate the effectiveness of silkworm pupae in improving sarcopenia, frailty and quality of life in AD patients?
- Does silkworm pupa powder improve cognitive function in AD patients?
Researchers will compare silkworm pupa powder to a placebo (a look-alike substance that contains no drug) to see if silkworm pupa powder works to improve the nutritional status of Alzheimer's disease patients.
Participants will:
- Take drug silkworm pupa powder or a placebo every day for 3 months.
- Visit the clinic once every 4 weeks for checkups and tests.
- Keep a diary of their daily consumption.
Sites (1)
- Hangzhou First People's Hospital, Hangzhou, Zhejiang, China